跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,972 条关于
“ARIA-E”
全部
8,972
临床试验
3,512
药物
1,032
机构
3,148
资讯
1,280
去年
Modified Donanemab Dosing Reduces ARIA-E Risk in Early Alzheimer's Patients
去年
Enhanced Donanemab Titration Reduces ARIA-E Risk in Alzheimer's Patients
去年
Gantenerumab's ARIA-E Risk Factors Identified in Alzheimer's Trials
去年
Donanemab's Modified Titration Significantly Reduces ARIA-E Risk in Alzheimer's Patients
去年
Eli Lilly's Kisunla Shows Reduced Brain Swelling with Modified Dosing in Alzheimer's Trial
去年
FDA Clears Icobrain Aria: AI Tool for Enhanced ARIA Detection in Alzheimer's Treatments
去年
Donanemab Treatment for Alzheimer's Disease Linked to Significant ARIA Risk, Analysis Reveals
去年
NICE Rejects Eli Lilly's Kisunla for Alzheimer's Despite UK Approval
去年
FDA Approves AI Tool icobrain aria for Detecting ARIA in Alzheimer's Immunotherapy Patients
7个月前
Brain Swelling from Alzheimer's Drugs May Signal Treatment Success, New Research Suggests
第 1 页,共 128 页
上一页
下一页